PANRETIN (alitretinoin)
TOPICAL ANTINEOPLASTIC RETINOIDS · KAPOSI'S SARCOMA SKIN LESION
CONCORDIA PHARM
Drug class
Topical Antineoplastic Retinoids
Topical antineoplastic retinoids are a specialized formulary subclass of locally applied vitamin A derivatives and rexinoids used to treat cutaneous malignancies. Read more about Topical Antineoplastic Retinoids
2 drugs in this class 2 manufacturers
Drugs in Topical Antineoplastic Retinoids
PANRETIN (alitretinoin)
TOPICAL ANTINEOPLASTIC RETINOIDS · KAPOSI'S SARCOMA SKIN LESION
ADVANZ PHARMA (
Filter & compare in the drug finder →
Opens the drug finder with Topical Antineoplastic Retinoids preselected. Add indication or manufacturer filters there.
Topical antineoplastic retinoids are a specialized formulary subclass of locally applied vitamin A derivatives and rexinoids used to treat cutaneous malignancies.
These agents, primarily including topical bexarotene and alitretinoin, bind intracellular retinoic acid receptors (RAR) and retinoid X receptors (RXR) to modulate gene expression, inducing cellular differentiation, inhibiting malignant proliferation, and promoting apoptosis.
Their primary therapeutic role is in managing skin lesions associated with early-stage or refractory cutaneous T-cell lymphoma, such as mycosis fungoides, as well as cutaneous manifestations of AIDS-related Kaposi sarcoma.
-
amazonaws.com
Topical antineoplastic retinoids are a specialized formulary subclass of locally applied vitamin A derivatives and rexinoids used to treat cutaneous malignancies These agents, primarily including topical bexarotene and alitretinoin, bind intracellular retinoic acid receptors (RAR) and retinoid X receptors (RXR) to modulate gene expression, inducing cellular differentiation, inhibiting malignant proliferation, and promoting apoptosis
-
rxlist.com
Topical antineoplastic retinoids are a specialized formulary subclass of locally applied vitamin A derivatives and rexinoids used to treat cutaneous malignancies These agents, primarily including topical bexarotene and alitretinoin, bind intracellular retinoic acid receptors (RAR) and retinoid X receptors (RXR) to modulate gene expression, inducing cellular differentiation, inhibiting malignant proliferation, and promoting apoptosis Their primary therapeutic role is in managing skin lesions asso...
-
sermo.com
Their primary therapeutic role is in managing skin lesions associated with early-stage or refractory cutaneous T-cell lymphoma, such as mycosis fungoides, as well as cutaneous manifestations of AIDS-related Kaposi sarcoma
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.